Publication | Open Access

A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin

Medicinal ChemistryDrug TargetHealth SciencesMedicineRational Drug DesignRilmenidine-derived CompoundsAntitumor EffectsPharmacotherapyStructure-based ApproachAnti-cancer AgentDrug DevelopmentPharmacologyRadiation OncologyPharmaceutical ChemistryDrug DiscoveryDrug Resistance